Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Change in Cash (2024 - 2025)

Profound Medical has reported Change in Cash over the past 2 years, most recently at $34.6 million for Q4 2025.

  • Quarterly results put Change in Cash at $34.6 million for Q4 2025, up 17.13% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (down 91.39% YoY), and the annual figure for FY2025 was $2.7 million, down 91.39%.
  • Change in Cash for Q4 2025 was $34.6 million at Profound Medical, up from -$9.6 million in the prior quarter.
  • Over the last five years, Change in Cash for PROF hit a ceiling of $34.6 million in Q4 2025 and a floor of -$13.7 million in Q2 2025.